2022
DOI: 10.1007/978-1-0716-2099-1_3
|View full text |Cite
|
Sign up to set email alerts
|

Microtumor Models as a Preclinical Investigational Platform for Photodynamic Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 39 publications
0
1
0
Order By: Relevance
“…Despite their significant size, M13 CC -RB phage bioconjugates display outstanding performances as targeted vector for PDT, deeply penetrating multicellular spheroids, and inducing light-dependent cytotoxic effects at picomolar concentrations. Spheroids represent a rapid screening method to assess the efficacy of PDT approaches, reducing the need of the highly relevant but low-throughput in vivo experiments for the preliminary assessment of PS uptake and penetration [ 58 ]. In general, the doses of phage at which lethal sensitization of CC cells could be observed (10^9–10^11 phages) is well compatible with phage intratumoral and intravenous (IV) injection in mouse tumor models [ 59 ], as well as for human administrations.…”
Section: Discussionmentioning
confidence: 99%
“…Despite their significant size, M13 CC -RB phage bioconjugates display outstanding performances as targeted vector for PDT, deeply penetrating multicellular spheroids, and inducing light-dependent cytotoxic effects at picomolar concentrations. Spheroids represent a rapid screening method to assess the efficacy of PDT approaches, reducing the need of the highly relevant but low-throughput in vivo experiments for the preliminary assessment of PS uptake and penetration [ 58 ]. In general, the doses of phage at which lethal sensitization of CC cells could be observed (10^9–10^11 phages) is well compatible with phage intratumoral and intravenous (IV) injection in mouse tumor models [ 59 ], as well as for human administrations.…”
Section: Discussionmentioning
confidence: 99%